Use of lysophosphatidic acid in the management of benign and malignant ovarian tumors.

Abstract

Determination of serum LPA would be an appropriate test for ovarian tumor presence, especially in women of reproductive age. The method however does not differentiate benign from malignant ovarian tumors.